TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 22 filers reported holding TRANSPHORM INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,241,538 | -7.1% | 1,009,702 | +42.3% | 0.05% | +16.3% |
| Q2 2023 | $2,412,980 | -14.8% | 709,700 | 0.0% | 0.04% | 0.0% |
| Q1 2023 | $2,831,703 | -26.7% | 709,700 | 0.0% | 0.04% | -8.5% |
| Q4 2022 | $3,860,768 | +8.1% | 709,700 | 0.0% | 0.05% | +9.3% |
| Q3 2022 | $3,570,000 | +32.0% | 709,700 | 0.0% | 0.04% | +38.7% |
| Q2 2022 | $2,704,000 | -55.9% | 709,700 | -18.2% | 0.03% | -53.0% |
| Q1 2022 | $6,133,000 | – | 867,500 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 609,170 | $4,307,000 | 1.99% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 374,226 | $2,646,000 | 1.61% |
| Kohlberg Kravis Roberts & Co. L.P. | 22,175,980 | $156,784,000 | 1.42% |
| Foundation Capital, LLC | 136,004 | $962,000 | 0.62% |
| Soros Fund Management | 673,991 | $4,765,000 | 0.07% |
| Polar Asset Management Partners Inc. | 867,500 | $6,133,000 | 0.07% |
| ExodusPoint Capital Management, LP | 89,499 | $633,000 | 0.01% |
| AMERIPRISE FINANCIAL INC | 3,602,481 | $25,470,000 | 0.01% |
| Weiss Asset Management LP | 43,600 | $308,000 | 0.01% |
| Ergoteles LLC | 18,900 | $134,000 | 0.01% |